Academic Journal
Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers
| العنوان: | Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers |
|---|---|
| المؤلفون: | Soria, J.C., Massard, C., Magne, N., Bader, Th., Mansfield, C.D., Blay, J.Y., Bui, B.N., Moussy, A., Hermine, O., Armand, J.P. |
| المساهمون: | Cytokines, hématopoïèse et réponse immune (CHRI), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS) |
| المصدر: | ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-00409171 ; European Journal of Cancer, 2009, ?, pp.?-?. |
| بيانات النشر: | HAL CCSD Elsevier |
| سنة النشر: | 2009 |
| الوصف: | International audience |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | hal-00409171; https://hal.science/hal-00409171 |
| الاتاحة: | https://hal.science/hal-00409171 |
| رقم الانضمام: | edsbas.FE6E809F |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |